Sign up for a new account.
And get access to
The latest T1D content
Research that matters
Our daily questions
Sign up by entering your info below.
Already have an account? Sign In
Sign in to your account with
Don't have an account? Sign Up
Reset Your Password
We will email you instructions to reset your
R.M Wolf1, N. Noor2, R. Izquierdo3, D. Jett3, A. Rewers4, S. Majidi4, N. Sheanon5, E. Breidbart6, C. Demeterco-Berggren7, J.M Lee8, M.K Kamboj9, O. Ebekozien10,2
1Johns Hopkins Medicine, Baltimore, USA, 2T1D Exchange, Boston, USA, 3SUNY Upstate Medical University, Albany, USA, 4Barbara Davis Center for Diabetes, Denver, USA, 5Cincinnati Children’s Hospital Medical Center, Cincinnati, USA, 6NYU Langone Pediatrics, New York City, USA, 7Rady Children’s Hospital, University of California, San Diego, San Diego, USA, 8Mott Children’s Hospital, Susan B. Meister Child Health Evaluation and Research Center, University of Michigan, Ann Arbor, USA, 9Nationwide Children’s Hospital, Columbus, USA, 10University of Mississippi Medical Center, Jackson, USA
Introduction: An increase in newly diagnosed type 1 diabetes (T1D) has been posited during the COVID-19 pandemic, but data have been conflicting.
Objectives: We aimed to determine trends in newly diagnosed T1D and severity of presentation at diagnosis for pediatric and adolescent patients during COVID-19 year (2020) as compared to the previous year (2019) in a multi-center data analysis across the United States.
“The Smart Insulin Pen”: A great tool for those who want the benefit of a pump but don't want to wear an insulin pump! A Qualitative Study on Facilitators to Smart Insulin Pump Use
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Increase in newly diagnosed type 1 diabetes among pediatric and adolescent patients during the COVID-19 pandemic in the United States: A multi-center analysis
You must be logged in to post a comment.